Cargando…

Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant

Detalles Bibliográficos
Autores principales:	Noh, Gwang Myeong, Nam, Ki Yup, Lee, Seung Uk, Lee, Sang Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685827/ https://www.ncbi.nlm.nih.gov/pubmed/31389218 http://dx.doi.org/10.3341/kjo.2018.0115

Ejemplares similares

Precipitation of Vancomycin and Ceftazidime on Intravitreal Injection in Endophthalmitis Patients
por: Noh, Gwang Myeong, et al.
Publicado: (2019)

Recurrent Enterococcus faecalis Endophthalmitis
por: Noh, Gwang Myeong, et al.
Publicado: (2019)

Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016)

The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018)

Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
por: Park, Sang-Uk, et al.
Publicado: (2014)

The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy
por: Mao, Jianbo, et al.
Publicado: (2019)

The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
por: Lim, Ji Won, et al.
Publicado: (2010)

Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy
por: Cuevas, Pedro, et al.
Publicado: (2012)

Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
por: Alishiri, Aliagha, et al.
Publicado: (2019)

Alternative management of central serous chorioretinopathy using intravitreal metoprolol
por: Gonçalves, Annelise Nicotti, et al.
Publicado: (2022)

Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy
por: Chung, Yoo-Ri, et al.
Publicado: (2022)

FUNDUS AUTOFLUORESCENCE PATTERNS IN CENTRAL SEROUS CHORIORETINOPATHY
por: Han, Jisang, et al.
Publicado: (2020)

Intravitreal Dexamethasone Implant with Plasma Autoantibody Monitoring for Cancer-associated Retinopathy
por: Kim, Min Seok, et al.
Publicado: (2019)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Management of Anterior Chamber Migration of Dexamethasone Intravitreal Implant
por: Ha, Jun Young, et al.
Publicado: (2017)

The Association between Choroidal Thickness Variations and Response to Intravitreal Bevacizumab in Central Serous Chorioretinopathy
por: Kim, Dong Yoon, et al.
Publicado: (2015)

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

External Subretinal Fluid Drainage and Vitrectomy in Exudative Retinal Detachment Secondary to Central Serous Chorioretinopathy: A Case Report
por: Moon, Ji Young, et al.
Publicado: (2022)

Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
por: Kang, Hae Min, et al.
Publicado: (2020)

Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop used Nasally for Rhinitis
por: Prakash, Gunjan, et al.
Publicado: (2013)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
por: Kelkar, Aditya, et al.
Publicado: (2014)

Comparison of oral propranolol, oral rifampicin, and intravitreal anti-VEGF in central serous chorioretinopathy
por: Sandeep, K, et al.
Publicado: (2023)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Central serous chorioretinopathy in pregnancy
por: Ochinciuc, Radu, et al.
Publicado: (2022)

Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy
por: Kwak, Jae Hyuck, et al.
Publicado: (2019)

Update on the pathophysiology and treatment of central serous chorioretinopathy
por: Yu, Seung-Young
Publicado: (2022)

Disc edema in one eye and central serous chorioretinopathy in the other eye shortly after AstraZeneca COVID‐19 vaccination
por: Lee, Daniel Yu, et al.
Publicado: (2021)

Traumatic central serous chorioretinopathy in the fellow eye
por: Yu, Seung-Young, et al.
Publicado: (2016)

Central serous chorioretinopathy following oral quetiapine
por: Durmaz Engin, Ceren, et al.
Publicado: (2023)

Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
por: G. Kotoula, Maria, et al.
Publicado: (2012)

Central serous chorioretinopathy secondary to trauma
por: Jackson, Thomas E., et al.
Publicado: (2012)

Central Serous Chorioretinopathy after Rhinoplasty
por: Moschos, Marilita M., et al.
Publicado: (2010)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f05i7u8ur36ppf0k7bhoh6ists